当前位置:首页 - 行情中心 - 益方生物-U(688382) - 财务分析

益方生物-U

(688382)

  

流通市值:129.93亿  总市值:179.92亿
流通股本:4.18亿   总股本:5.78亿

益方生物-U(688382)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润-1.19亿元,每股收益-0.21元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益171810.22万元,未分配利润-266435.82万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产181296.82万元,负债9486.60万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入19,163,847.378,188,968.92168,790,397.5619,156,299.24
营业总成本131,684,739.565,993,855.34410,066,940.31327,620,052.49
其他经营收益
营业利润-119,432,479.85-57,499,070.16-240,203,844.86-305,306,509.72
利润总额-119,432,479.85-57,499,070.16-240,203,844.86-305,306,509.72
净利润-119,432,479.85-57,499,070.16-240,203,844.86-305,306,509.72
每股收益
其他综合收益-463,965.38-502,494.69-1,159,124.87-1,629,834.88
综合收益总额-119,896,445.23-58,001,564.85-241,362,969.73-306,936,344.6
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计1,759,896,254.061,823,300,104.91,870,110,649.461,831,610,771.86
非流动资产:
非流动资产合计53,071,913.549,997,047.5850,706,524.7959,796,518.76
资产总计1,812,968,167.561,873,297,152.471,920,817,174.251,891,407,290.62
流动负债:
流动负债合计75,955,262.6980,698,375.2589,980,444.66133,028,955.87
非流动负债:
非流动负债合计18,910,729.422,356,364.8720,053,516.5123,401,496.67
负债合计94,865,992.09103,054,740.11110,033,961.17156,430,452.54
所有者权益(或股东权益):
归属于母公司股东权益合计1,718,102,175.471,770,242,412.361,810,783,213.081,734,976,838.08
股东权益合计1,718,102,175.471,770,242,412.361,810,783,213.081,734,976,838.08
负债和股东权益合计1,812,968,167.561,873,297,152.471,920,817,174.251,891,407,290.62
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计23,715,927.082,477,134.27156,323,577.1132,905,278.31
经营活动现金流出小计130,965,827.4464,502,086.88398,296,432.72322,507,987.06
经营活动产生的现金流量净额-107,249,900.35-62,024,952.61-241,972,855.61-289,602,708.75
投资活动产生的现金流量:
投资活动现金流入小计212,084,099.81-721,153,504.26-
投资活动现金流出小计505,436,399.7259,625,660.39775,082,152.11181,557,575.16
投资活动产生的现金流量净额-293,352,299.89-259,625,660.39-53,928,647.85-181,557,575.16
筹资活动产生的现金流量:
筹资活动现金流入小计6,884,523.156,884,523.157,591,598.257,591,598.25
筹资活动现金流出小计3,695,841.81,336,656.214,072,917.0510,058,462.33
筹资活动产生的现金流量净额3,188,681.355,547,866.95-6,481,318.8-2,466,864.08
汇率变动对现金及现金等价物的影响-905,461.13-658,193.82503,717.88-2,674,530.71
现金及现金等价物净增加额-398,318,980.03-316,760,939.87-301,879,104.38-476,301,678.7
期末现金及现金等价物余额515,627,588.16597,185,628.32913,946,568.19739,523,993.87
补充资料:
现金及现金等价物的净增加额-398,318,980.03--301,879,104.38-
最新报告期:2025-09-09
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
华西证券崔文亮-0.35-0.24-0.332025-09-09
天风证券杨松,曹文清-0.42-0.38-0.252025-09-09
东方证券伍云飞-0.35-0.39-0.162025-09-03
光大证券张瀚予,王明瑞-0.44-0.39-0.082025-08-28
TOP↑